Literature DB >> 26896092

Risk of Venous Thromboembolism in Patients with Large Hemispheric Infarction Undergoing Decompressive Hemicraniectomy.

Nohra Chalouhi1, Badih Daou1, Fred Rincon1, Maria Montano1, Anthony Kent1, Kaitlyn Barkley1, Robert M Starke1, Stavropoula Tjoumakaris1, David Hasan2, Richard Dalyai1, Robert Rosenwasser1, Pascal Jabbour3,4.   

Abstract

BACKGROUND: Deep-venous thrombosis (DVT) and pulmonary embolism (PE) are major causes of morbidity and mortality in patients with acute ischemic stroke. This study is the first to examine the risk of venous thromboembolism in patients with large hemispheric infarction undergoing decompressive hemicraniectomy.
METHODS: The study population included 95 consecutive patients with a large hemispheric infarction who underwent decompressive hemicraniectomy between 2006 and 2014 at our institution. All patients received prophylactic unfractionated heparin and intermittent compression devices (SCD). Patients were systematically screened for DVT at 5-day interval using Duplex ultrasound. PE was diagnosed on chest CT angiography.
RESULTS: Mean age was 57 ± 12 years; mean BMI was 28.3 ± 7.4 kg/m(2). 30.5 % of patients had infarction in the dominant hemisphere and 69.5 % in the non-dominant hemisphere. The mean NIHSS score was 16.0 ± 5 at admission. The mean length of stay was 22 ± 17 days. 35 % of patients developed a DVT including 27 % who developed above-knee DVT and required placement of an inferior vena cava filter. In multivariable analysis, predictors of DVT were an NIHSS ≥ 17 (p = 0.007), seizures (p = 0.003), hypertension (p = 0.03), and increasing length of stay (p = 0.01). The proportion of patients who developed PE was 13 %. In multivariate analysis, BMI ≥ 30 predicted PE (p = 0.05).
CONCLUSIONS: The rate of DVT and PE is remarkably high in patients with large hemispheric infarction undergoing decompressive hemicraniectomy despite prophylactic measures. We recommend routine screening for DVT in this population. Interventions beyond the standard prophylactic measures may be necessary in this high-risk group.

Entities:  

Keywords:  Decompressive hemicraniectomy; Stroke; Venous thromboembolism

Mesh:

Year:  2016        PMID: 26896092     DOI: 10.1007/s12028-016-0252-z

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  15 in total

1.  Evidence-based guidelines for the management of large hemispheric infarction : a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine.

Authors:  Michel T Torbey; Julian Bösel; Denise H Rhoney; Fred Rincon; Dimitre Staykov; Arun P Amar; Panayiotis N Varelas; Eric Jüttler; DaiWai Olson; Hagen B Huttner; Klaus Zweckberger; Kevin N Sheth; Christian Dohmen; Ansgar M Brambrink; Stephan A Mayer; Osama O Zaidat; Werner Hacke; Stefan Schwab
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

2.  Risk factors for venous thromboembolism in patients undergoing craniotomy for neoplastic disease.

Authors:  Kristopher T Kimmell; Kevin A Walter
Journal:  J Neurooncol       Date:  2014-08-23       Impact factor: 4.130

3.  Risk of venous thromboembolism in people with epilepsy.

Authors:  Gabriel U Martz; Dulaney A Wilson; Angela M Malek; Anbesaw W Selassie
Journal:  Epilepsia       Date:  2014-09-30       Impact factor: 5.864

4.  Is prophylactic anticoagulation for deep venous thrombosis common practice after intracerebral hemorrhage?

Authors:  Shyam Prabhakaran; Patricia Herbers; Jane Khoury; Opeolu Adeoye; Pooja Khatri; Simona Ferioli; Dawn O Kleindorfer
Journal:  Stroke       Date:  2015-01-08       Impact factor: 7.914

5.  Clinical factors associated with venous thromboembolism risk in patients undergoing craniotomy.

Authors:  Kristopher T Kimmell; Babak S Jahromi
Journal:  J Neurosurg       Date:  2014-12-12       Impact factor: 5.115

6.  Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging.

Authors:  J Kelly; A Rudd; R R Lewis; C Coshall; A Moody; B J Hunt
Journal:  Stroke       Date:  2004-08-19       Impact factor: 7.914

Review 7.  Prevention of venous thromboembolism in patients with hemorrhagic stroke.

Authors:  Farrukh S Chaudhry; Michael J Schneck; Sarkis Morales-Vidal; Furqan Javaid; Sean Ruland
Journal:  Top Stroke Rehabil       Date:  2013 Mar-Apr       Impact factor: 2.119

Review 8.  Prophylaxis of Venous Thrombosis in Neurocritical Care Patients: An Evidence-Based Guideline: A Statement for Healthcare Professionals from the Neurocritical Care Society.

Authors:  Paul Nyquist; Cynthia Bautista; Draga Jichici; Joseph Burns; Sanjeev Chhangani; Michele DeFilippis; Fernando D Goldenberg; Keri Kim; Xi Liu-DeRyke; William Mack; Kim Meyer
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

9.  Cardiovascular risk factors and venous thromboembolism: a meta-analysis.

Authors:  Walter Ageno; Cecilia Becattini; Timothy Brighton; Rita Selby; Pieter W Kamphuisen
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

Review 10.  Prophylaxis for venous thrombo-embolism in neurocritical care: a critical appraisal.

Authors:  Ahmed M Raslan; Jeremy D Fields; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

View more
  2 in total

1.  Stroke-related complications in large hemisphere infarction: incidence and influence on unfavorable outcome.

Authors:  Jie Li; Ping Zhang; Simiao Wu; Yanfen Wang; Ju Zhou; Xingyang Yi; Chun Wang
Journal:  Ther Adv Neurol Disord       Date:  2019-08-30       Impact factor: 6.570

2.  Myocardial Infarction Is Associated With Increased Stroke Severity, In-Hospital Mortality, and Complications: Insights From China Stroke Center Alliance Registries.

Authors:  Hongzhou Duan; Zixiao Li; Hong-Qiu Gu; Qi Zhou; Xu Tong; Gaoting Ma; Bo Wang; Baixue Jia; Yilong Wang; Zhongrong Miao; Yongjun Wang; Dapeng Mo
Journal:  J Am Heart Assoc       Date:  2021-10-06       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.